Bemotrizinol Effective Date: What Actually Changes on August 9
Two dates keep showing up in the same sentence, and they’re doing different jobs. The FDA issued its bemotrizinol order in June. The order itself doesn’t start working until August 9, 2026. So what’s the gap for, and what’s actually different once the second date passes? We read the order, all 36 pages of it, so here’s the plain version.
The short version: The bemotrizinol effective date is August 9, 2026, written into Section VI of FDA final order OTC000039.[2] From that day, a sunscreen containing bemotrizinol can be legally sold in the US without its own drug application, provided it meets four conditions: no more than 6 percent bemotrizinol, a finished SPF of at least 2, no mixing with PABA or trolamine salicylate, and one of nine permitted formats.[2] The same order also hands DSM Nutritional Products, plus its licensees, 18 months of exclusive rights starting from that date.[2] Nothing on your bathroom shelf changes, and this is a US rule only.
The bemotrizinol effective date is August 9, not the day the FDA issued the order
The paperwork ran in this order, and each step has its own date:
| Date | What happened |
|---|---|
| September 23, 2024 | DSM Nutritional Products filed a Tier 1 request, the route a company uses to ask the FDA to add an ingredient to a monograph, asking the FDA to add bemotrizinol at up to 6 percent [1] |
| December 12, 2025 | The FDA published its proposed order [1] |
| June 9 to 10, 2026 | The notice was filed on the 9th and printed in the Federal Register on the 10th. The final order document carries the date June 10, 2026 [1][2] |
| August 9, 2026 | The final order takes effect [2] |
One thing worth knowing if you go looking for this yourself: the Federal Register piece is labeled a notice of availability. Its job is to tell you the order exists and where to find it. The effective date, the conditions, and the exclusivity all sit in the separate order document on the FDA’s monograph portal.[1][3] That’s why news coverage of this varies so much depending on which file the writer opened.
The FDA took about 50 comments on the proposal,[2] and its own summary says it made no changes to the final order after reading them.[1]
What actually becomes legal that day
Short answer: a category of product, not a specific bottle.
In the US, sunscreen counts as a drug rather than a cosmetic, which is why your bottle carries a Drug Facts panel. A company can skip the full drug application process only if its product matches a monograph, which is the rulebook for that category. Sunscreen’s rulebook is called Monograph M020.[1] Before this order, bemotrizinol wasn’t in it, so there was no monograph route for a US sunscreen using it.
What the order does is add bemotrizinol to that rulebook. From August 9, a sunscreen with bemotrizinol in it can be sold in the US without its own approved application, provided it follows the conditions the order sets.[2] That’s the change. It’s a door opening, not a product launching.
Why won’t I see it in every sunscreen right away?
Because the order names one company. Section V says the order authorizes solely DSM Nutritional Products, along with its licensees, assignees, or successors in interest, to sell products using this change. That exclusivity lasts 18 months, counted from the effective date and starting when DSM may lawfully sell under the order.[2]
DSM is the company that asked for the change in the first place, back in September 2024, and it’s also the supplier that sells the filter.[1] So the practical shape of the next year and a half is DSM and the brands that license from it, rather than an open field on day one.
We’re not going to guess at launch dates here. The order doesn’t contain any, and we haven’t seen a shipping product, so anything past this point would be a prediction rather than a fact.
The conditions the order attaches to bemotrizinol
These are the specific tests a US product has to pass to use the monograph route. All four come straight from the order.[2]
- Up to 6 percent. The FDA spells out that “up to 6 percent” means up to and including 6 percent, so 6.0 is allowed and 6.1 isn’t.
- The finished product needs an SPF of at least 2, measured by the SPF test procedure already written into Monograph M020. That’s a floor for the bottle, not for the filter.
- Two ingredients are off limits as partners. A product combining bemotrizinol with PABA or trolamine salicylate is not considered safe and effective, so those pairings can’t use this route. Other permitted sunscreen filters, and some skin protectant ingredients, are allowed under further conditions.
- Nine formats only: oil, lotion, cream, gel, butter, paste, ointment, stick, and spray.
That last one has a catch that’s easy to miss. A spray qualifies only if it uses no propellant, like a pump spray, or keeps the propellant fully separated from the formula inside the can, like a bag-on-valve design. The FDA says the data don’t support mixing the formula directly with a propellant to make an aerosol, and they don’t support a powder either.[2] So a US bemotrizinol sunscreen in classic aerosol or powder form isn’t on the table under this order.
On safety, the FDA concluded there’s adequate evidence for bemotrizinol at up to 6 percent for adults and children 6 months of age and older.[2]
Does my sunscreen label change?
No. The FDA looked at exactly this question and concluded there’s no safety or efficacy reason to amend the labeling rules in Monograph M020 for products containing bemotrizinol.[2] A US sunscreen using it will carry the same Drug Facts panel format as any other, with bemotrizinol listed among the active ingredients.
There’s one more thing the order doesn’t settle. A separate proposed order from 2021, OTC000008, would revise Monograph M020 more broadly, and this bemotrizinol order deliberately doesn’t address it. If that one is ever finalized, every sunscreen sold under M020, including any using bemotrizinol, would have to meet the revised conditions.[2] So August 9 settles one filter, not the whole rulebook.
Does any of this touch the Korean sunscreen I already own?
Not in any way you’d notice. This order changes what can be sold in the US under the US monograph. It isn’t a Korean rule, it isn’t a European rule, and it doesn’t reach back to anything already in your bathroom. Nothing was recalled and no product stopped being what it was.
If you want the parts this piece deliberately skips, we’ve covered them separately. Our bemotrizinol news explainer covers what the filter is and why the US list stayed frozen for so long. Our guide to Korean sunscreen filters walks through the modern filters one by one. And if you’ve noticed that the same Korean product can have a different ingredient list depending on where you bought it, our piece on US versions of Korean sunscreens explains how that happens.
FAQ
I keep seeing two dates. What is the bemotrizinol effective date?
August 9, 2026. Section VI of FDA final order OTC000039 says the order takes effect on that date, unless the order is disputed under the relevant part of the Food, Drug, and Cosmetic Act.[2]
Can I buy a US sunscreen with bemotrizinol on August 9?
The order makes it legal to sell one from that date, but it doesn’t put anything in a store. It also gives DSM Nutritional Products and its licensees 18 months of exclusive rights starting from the effective date, so the range of brands able to sell one during that window is limited by the order itself.[2]
How much bemotrizinol is allowed in a sunscreen I buy in the US?
Under this order, a US monograph sunscreen can contain up to and including 6 percent, and the finished bottle has to test at SPF 2 or higher. The FDA found adequate evidence of safety and efficacy at that level for adults and children 6 months of age and older.[2]
Am I going to see it in a spray or a powder?
A spray, possibly, but only a pump spray or a bag-on-valve type where the propellant never touches the formula. A regular aerosol spray and a powder are both outside what this order permits.[2]
Do I need to do anything before August 9?
No. This is a rule about what companies may sell in the US, not a rule about what you may use. Your current sunscreen is unaffected either way.
Sources
Primary regulatory documents, read in full on 2026-07-28:
[1] Federal Register, “Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information,” Vol. 91, No. 111, June 10, 2026, pages 35220 to 35221, Docket No. FDA-2025-N-6494. Notice of availability. Confirms the 6 percent limit, the September 23, 2024 request from DSM, the December 12, 2025 proposed order, the nine permitted dosage forms, and that no changes were made after comments. Full text via the Government Publishing Office: link
[2] U.S. Food and Drug Administration, Final Administrative Order OTC000039, issued June 10, 2026, 36 pages. Source for the August 9, 2026 effective date (Section VI), the 18 month exclusivity for DSM and its licensees (Section V), the “up to and including 6 percent” reading, the minimum SPF of 2, the PABA and trolamine salicylate exclusion, the spray and powder limits, the finding that no labeling change is needed, and the note that proposed order OTC000008 remains unaddressed: link
[3] OTC Monographs@FDA portal, order detail page for OTC000039, listing the final order and its supporting scientific and environmental documents: link
